Animal studies using TZDs in models of NAFLD have been of limited value as full agonism of PPARΥ can promote hepatic lipogenesis, which contrasts with the findings seen in human studies. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.